Effect of interferon-γ, in vitro and in vivo, on mRNA levels of phagocyte oxidase components

Journal of Leukocyte Biology

Volumn 60, Issue 6, 1996, Pages 716-720

  Weening, Ron S ^a,b,c   De Klein, Angelique ^a   De Boer, Martin ^a   Roos, Dirk ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

chronic granulomatous disease; NADPH oxidase

Indexed keywords

MESSENGER RNA; PLACEBO; RECOMBINANT GAMMA INTERFERON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030467121     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.6.716     Document Type: Article

References (32)

1. Forrest, C. B, Forehand, J. R., Axtell, R. A., Roberts, R. L., Johnston, R. B. (1988) Clinical features and current management of chronic granulomatous disease. Hematol. Oncol. Clin. N. Am. 2, 253-267.
2. Curnutte, J. T., Whitten, D. M., Babior, B. M. (1974) Defective Superoxide production by granulocytes from patients with chronic granulomatous disease. N. Engl. J. Med. 290, 593-597.
3. Volpp, B. D., Nauseef, W. M., Clark, R. A. (1988) Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242, 1295-1297.
4. Royer-Pokora, R, Kunkel, L. M., Monaco, A. P., Goff, S. C., Newburger, P. E., Baehner, R. L., Cole, F. S., Curnutte, J. T., Orkin, S. H. (1986) Cloning of the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322, 32-38.
5. Dinauer, M. C., Orkin, S. H., Brown, R., Jesaitis, A. J., Parkos, C. A. (1987) The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327, 717-720.
6. 245. Nature 327, 720-721.
7. Parkos, C. A., Dinauer, M. C., Walker, L. E., Allen, R. A., Jesaitis, A. J., Orkin, S. H. (1988) Primary structure and unique expression of the 22 kilodalton light chain of human neutrophil cytochrome b. Proc. Nail. Acad. Sci. USA 85, 3319-3323.
8. 2 oxidoreductase in human neutrophils after stimulation with phorbol-myristate acetate. J. Biol. Chem. 265, 924-930. [Correction: 265, 19370-19371.]
9. Clark, R. A., Volpp, B. D., Leidal, K. G., Nauseef, W. M. (1990) Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J. Clin, Invest. 85, 714-721.
10. Roos, D., De Boer, M., Kuribayashi, F., Meischl, C., Weening, R. S., Segal, A. W., Ahlin, A., Nemet, K., Hossle, J. P., Bernatowska-Matuszkiewicz, E., Middleton-Price, H. (1996) Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87, 1663-1681.
11. Dinauer, M. C., Pierce, E. A., Bruns, G. A. P., Curnutte, J. T., Orkin, S. H. (1990) Human neutrophil cytocrome-b light chain (p22-phox): Gene structure, chromosomal location, and mutations in cytochrome b negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 86, 1729-1737.
12. Volpp, B. D., Nauseef, W. M., Donelson, J. E., Moser, D. R., Clark, R. A. (1989) Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc. Natl. Acad. Sci. USA 86, 7195-7199. [Erratum: 86, 9563.]
13. Lomax, K. R., Leto, T. L., Nunoi, H., Gallin, J. I., Malech, H. L. (1989) Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245, 409-412. [Erratum: 246, 987.]
14. c-src. Science 248, 727-730.
15. Francke, U., Hsieh, C.-L., Foellmer, B. E., Lomax, K. J., Malech, H. L., Leto, T. L. (1990) Genes for two autosomal recessive forms of chronic granulomatous disease assigned to Iq25 (NCF2) and 7q11.23 (NCF1). Am. J. Hum. Genet. 47, 483-492.
16. Nathan, C. F., Murray, H. W., Wiebe, M. E., Rubin, B. Y. (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689.
17. Berton, G., Zeni, L., Cassatella, M. A., Rossi, F. (1986) Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem. Biophys. Res. Commun. 138, 1276-1282.
18. Ezekowitz, R. A. B., Orkin, S. H., Newburger, P. E. (1987) Recombinant interferon-gamma augments phagocyte Superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J. Clin. Invest. 80, 1009-1016.
19. The International Chronic Granulomatous Disease Cooperative Study Group (1991). A controlled trial of interferon-gamma to prevent infection in chronic granulomatous disease. N. Engl. J. Med. 324, 509-516.
20. Ezekowitz, R. A. B., Dinauer, M. C., Jaffe, H. S., Newburger, P. E. (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon-gamma. N. Engl. J. Med. 319, 146-151.
21. Sechler, J. M. G., Malech, H. L., White, C. J., Gallin, J. I. (1988) Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc. Natl. Acad. Sci. USA 85, 4874-4878.
22. Roos, D., de Boer, M. (1986) Purification and cryopreservation of phagocytes from human blood. Methods in Enzymology, Vol. 132, Immunocytochemical Techniques, Part J. Phagocytosis and Cell-mediated Cytotoxicity (G. di Sabato and J. Everse, eds.) New York, Academic, 225-243.
23. Chirgwin, J. M., Przybyla, A. E., Mac Donald, R. J., Rutter, W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
24. Sambrook, J., Fritsch, E., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual (2nd ed.) Cold Spring Harbor, NY, Cold Spring Harbor Laboratory.
25. 558 of human neutrophils. Blood 73, 1686-1694.
26. De Boer, M., Hilarius-Stokman, P. M., Hossle, J. P., Verhoeven, A. J., Graf, N., Kenney, J. T., Seger, R., Roos, D. (1994) Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: Identification of mutation and detection of carriers. Blood 83, 531-536.
27. Cassatella, M. A., Bazzoni, F., Flynn, R. M., Dusi, S., Trinchieri, G., Rossi, F. (1990) Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability. J. Biol. Chem. 265, 20241-20246.
28. Amezaga, M. A., Bazzoni, F., Sorio, C., Rossi, F., Cassatella, M. A. (1992) Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon-γ-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox and p22-phox) and high-affinity receptor for IgG (FcyR-I) in human polymorphonuclear leukocytes. Blood 79, 735-744.
29. Mühlebach, T. J., Gabay, J., Nathan, C. F., Erny, C., Dopfer, G., Schroten, H., Wahn, V., Seger, R. A. (1992) Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve oxidative metabolism, cytochrome b558 content or levels of four antimicrobial proteins. Clin. Exp. Immunol. 88, 203-206.
30. Bermudez, L. E., Inderlied, C., Young, L. S. (1991) Stimulation with cytokines enhances penetration of azithromycin into human macrophages. Antimicrob. Agents and Actions 35, 2625-2629.
31. Ding, A. H., Nathan, C. F., Stuehr, D. J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
32. Huizinga, T. W. J., van der Schoot, C. E., Roos, D., Weening, R. S. (1991) Induction of neutrophil Fc-gamma receptor I expression can be used as a marker for biological activity of recombinant interferon-gamma in vivo. Blood 77, 2088-2090.